Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 26Gastrointestinal 7Gynecologic 5Tumor-Agnostic 4Thoracic 4Other hematologic neoplasm 3Genitourinary 3CNS 3Sarcoma 2Other 2Lymphoid 2Head & Neck 2Endocrine 2Other solid neoplasm 1

Conditions

Smoking Cessation 1Smoking 1Pituitary Neoplasms 1Multiple Endocrine Neoplasia Type 1 1

Interventions

Everolimus 61lutetium Lu 177 dotatate 53Magnetic Resonance Spectroscopy 39pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 25lanreotide 24gallium Ga 68 dotatate 24cabozantinib 22pasireotide 21lenvatinib 203-Iodobenzylguanidine 20Etoposide 19Sunitinib 18Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18surufatinib 16Bevacizumab 16trametinib 15dabrafenib 15Sorafenib 14Doxorubicin 14Ipilimumab 13Thyrotropin Alfa 12Surgical Procedures, Operative 12Injections 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Yoga × Endocrine × Clear all
NCT04284605 2021-10-27

Effects Exercise Training in Patients With Pituitary Adenoma

Hacettepe University

Phase NA Completed
10 enrolled
Endocrine

Pituitary Neoplasms

NCT02055326 2014-02-05

Yoga for Men Attempting Smoking Cessation

The Miriam Hospital

Phase NA Completed
38 enrolled
Endocrine

Smoking, Smoking Cessation, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡